Onward Medical NV (CHIX:ONWDB) Profitability Rank: 0 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ONWDB Onward Medical NV CHIX:ONWDB
33 GF Score
Price €6.12
GF Value €365.78
! 4 Warning Signs
View Full Analysis

What is Onward Medical NV Profitability Rank?

Onward Medical NV has the Profitability Rank of 0.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is rated on a scale of 1 to 10 and is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

A higher score indicates superior profitability, with companies rated 7 or above considered to have more robust and sustainable profit generation. Conversely, a score of 3 or lower suggests challenges in generating consistent profits.

Onward Medical NV's Operating Margin % for the quarter that ended in Dec. 2025 was -762.95%. As of today, Onward Medical NV's Piotroski F-Score is 4.


Onward Medical NV Profitability Rank Related Terms


CHIX:ONWDB vs VRTX, REGN, RVMD: Profitability Rank Comparison

For the Biotechnology subindustry, Onward Medical NV's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onward Medical NV Profitability Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's Profitability Rank falls into.


CHIX:ONWDB
33GF Score
Onward Medical NV CHIX:ONWDB
Profitability Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onward Medical NV Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The rank is rated on a scale of 1 to 10. A higher score indicates superior profitability, with companies rated 7 or above considered to have more robust and sustainable profit generation. Conversely, a score of 3 or lower suggests challenges in generating consistent profits.

Onward Medical NV has the Profitability Rank of 0.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Onward Medical NV's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-20.943 / 2.745
=-762.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Onward Medical NV has an F-score of 4 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank

Is Onward Medical NV (CHIX:ONWDB) Overvalued in 2026?

Based on GuruFocus' analysis, Onward Medical NV stock appears to be undervalued. The current stock price of €6.12 is trading 98.3% below its estimated GF Value™ of €365.78.

Key valuation signals for CHIX:ONWDB:

  • Profitability Rank: 0
  • GF Value™: €365.78 vs. price of €6.12 (98.3% below fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the CHIX:ONWDB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Onward Medical NV Business Description

Address Schimmelt 2, Eindhoven, NH, NLD, NL-5656
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
33GF Score

Get the complete analysis for CHIX:ONWDB

Profitability Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.12
Price
€365.78
GF Value